Cargando…
Modified Thymosin Alpha 1 Distributes and Inhibits the Growth of Lung Cancer in Vivo
[Image: see text] Targeted therapy of tumors is an effective method for treating cancer. Thymosin alpha 1 (Tα1), a hormone that contains 28 amino acids, is already approved for cancer treatment. However, its clinical application is limited because of the lack of tumor targeting. Considering that RGD...
Autores principales: | Peng, Renhao, Xu, Caoying, Zheng, Heng, Lao, Xingzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226852/ https://www.ncbi.nlm.nih.gov/pubmed/32426594 http://dx.doi.org/10.1021/acsomega.0c00220 |
Ejemplares similares
-
A Tumor-Penetrating Peptide Modification Enhances the Antitumor Activity of Thymosin Alpha 1
por: Lao, Xingzhen, et al.
Publicado: (2013) -
Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life
por: Wang, Fanwen, et al.
Publicado: (2018) -
A Reappraisal of Thymosin Alpha1 in Cancer Therapy
por: Costantini, Claudio, et al.
Publicado: (2019) -
Effects on tumor growth and immunosuppression of a modified Tα1 peptide along with its circular dichroism spectroscopy data
por: Wang, Fanwen, et al.
Publicado: (2018) -
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections
por: Bellet, Marina M., et al.
Publicado: (2023)